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The Helicobacter pylori protein CagA (cytotoxin-associated
gene A) is associated with an increased risk for gastric cancer
formation. After attachment to epithelial cells, the bacteria
inject CagA via a type IV secretion apparatus into host cells,
where it exerts its biological activity. Host cell responses to
intracellular CagA have been linked exclusively to signaling
motifs in the C terminus of the CagA protein. Little is known
about the functional role of the remaining CagA protein. Using
transgenic expression of CagA mutants in epithelial cells, we
were able to identify a novel CagA inhibitory domain at the N
terminus consisting of the first 200 amino acids. This domain
localizes to cell-cell contacts and increases the rate and strength
of cell-cell adhesion in epithelial cells. Thus, it compensates for
the loss of cell-cell adhesion induced by the C terminus of the
CagA protein. Consistent with its stabilizing role on cell-cell
adhesion, the CagA N terminus domain reduces the CagA-in-
duced-catenin transcriptional activity in the nucleus. Further-
more, it inhibits apical surface constriction and cell elongations,
host cell phenotypes induced by the C terminus in polarized
epithelia. Therefore, our study suggests that CagA contains an
intrinsic inhibitory domain that reduces host cell responses to
CagA, which have been associated with the formation of cancer.
Helicobacter pylori infection is a well established risk factor
for gastric cancer. Epidemiological data suggest that 60–90% of
all gastric cancer is attributed to H. pylori infection (1, 2). The
relative risk for gastric cancer is higher when patients are
infected with CagA (cytotoxin-associated gene A)-positive H.
pylori strains comparedwithCagA-negative strains (3, 4). Stud-
ies in animal models support the epidemiological evidence that
CagA is an important virulence factor for gastric cancer. In
mongolian gerbils chronic infection with CagA H. pylori, but
not aH. pylorimutant strain lacking CagA, causes early immu-
nological responses, which eventually leads to precancerous
gastric changes (5). Data from transgenic expression of CagA in
a mouse model suggest that CagA causes the formation of gas-
tric neoplasms even independent of chronicH. pylori infection
(6, 7).
CagA is part of the cag pathogenicity island, a set of genomic
DNA that also encodes for a type IV secretion system. After
attachment of H. pylori to epithelial cells, CagA is injected via
the type IV secretion system into host cells and consecutively
phosphorylated by host Src kinases and c-Abl at tyrosine resi-
dues of EPIYA motifs in the C terminus of the protein (8–13).
As a result, epithelial gastric carcinoma cells elicit growth fac-
tor-like responses such as cell scattering, elongation, and
migration (14–18). CagA also has phosphorylation-indepen-
dent effects on host cell signaling pathways (19–22).
CM/CRPIAmotifs in the C terminus of CagA contribute to cell
scattering and mediate NF-B and TCF/-catenin3 transcrip-
tional activity (23).
CagA-induced host signaling has been attributed exclusively
to signalingmotifs located in theC terminus ofCagA (24). Little
is known about the role of the remaining part, theN terminus of
CagA, which accounts for two-thirds of the CagA protein. Bag-
noli et al. (25) demonstrated that the N terminus of CagA
directs the protein to the plasma membrane of epithelial cells
independent of the C terminus. However, data regarding the
mechanism of CagA interaction with the epithelial membrane
appear to be inconsistent. Higashi et al. (16, 26) described that
the EPIYAmotifs in the C terminus are required formembrane
attachment, thereby initiating EPIYA-induced host signaling.
Therefore, we asked the question how the N terminus of
CagA affects host cell physiology, both dependent and inde-
pendent of signaling motifs in the CagA C terminus. In this
manuscript we present data showing that CagA consists of two
independent domains at the N and C termini of the protein,
respectively, with which the protein tethers to structures at the
plasma membrane of host cells. The first 200 AA of the N ter-
minus of CagA act as an inhibitory domain of host cell
responses evoked by the CagA C terminus: (i) it increases the
rate and strength of newly formed cell-cell contacts, (ii) it
decreases cell elongation and constriction of the apical mem-
brane induced by the C terminus, and (iii) it reduces TCF/-
catenin transcriptional activity mediated by the C terminus of
CagA.
EXPERIMENTAL PROCEDURES
Cell Lines—Mardin-Darby canine kidney (MDCK) II cells
were cultured in DMEM (Invitrogen) containing 10% fetal
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bovine serum as described before (27). For MDCK II cells to
polarize, 5  105 cells were plated on Transwell filters (12-mm
well, 0.4-m pore size; Corning) and incubated for 2 days
before transfection experiments. The gastric cell line NCI-N87
was obtained from American Type Culture Collection and
maintained in recommended culture conditions. Lipo-
fectamine LTX (Invitrogen) was used for transfection of plas-
mid cDNA according to the manufacturer’s manual. Inducible
expression of CagA and CagA mutants in MDCK II cell lines
was generated via the Tet-On advanced inducible gene
expression system (Clontech). For induction of protein expres-
sion, 3 g/ml doxycycline was added to cell culture medium
24 h prior to experiments.
Plasmids—For CagA cloning, we modified the pTRE-tight
vector from Clontech as follows. The multiple cloning site was
replaced by enhanced GFP from Clontech vector pEGFP at the
N terminus and the SBP/CBP tag from vector pCTAP (Strat-
agene) at the C terminus. CagA constructs were generated by
PCR from previously published pEGFP-CagAWT plasmid (H.
pylori strain G27 (25)). CagA mutants 1–200, 1–150, 27–225,
and 200–800were cloned in-framebetweenGFP andSBP/CBP
via SalI/NotI. CagAmutants 200–1216, 400–1216, and 200–
800 were cloned by replacing the SBP/CBP tag with a CagA
800–1216 PCR product via NotI/XbaI. Respective CagA PCR
products 200–800, 400–800, 1–200, and 27–800 were cloned
in-frame between GFP and CagA 800–1216 via SalI/NotI. For
co-expression experiments, CagA 871–1216 was cloned by
replacing the SBP/CBP tag with a respective PCR product via
NotI/XbaI. For RFP tagging of CagA 871–1216 and CagA 200–
1216, enhanced GFP was replaced by monomeric RFP (28).
CagA WT was inserted in-frame via Eco47III/NotI into a
pTRE-Myc vector (Clontech) with the modified multiple clon-
ing site (25). In a second step, GFP-CagA WT was cloned via
BamHI/NotI into the above-mentioned modified pTRE-tight
vector and therefore includes in addition an N-terminal Myc
tag. For CagA EPISA C, a chemically synthesized cDNA frag-
ment encoding for AA 943–1055 with both EPIYA C motifs
mutated to EPISA C was inserted into CagA Par1 via AscI/
XbaI. CagA Par1 was cloned by replacing AA 943–1027 with
an AscI restriction site in CagA WT. Because of technical
requirements, synthesis of the EPISA C fragment required a
change in codon usage (from Canis familaris) optimized by
GENEius software (Eurofins) (supplemental Fig. S1).
Immunofluorescence—For confocal immunofluorescence
microscopy, the cells were fixed with 2% paraformaldehyde in
100 mM sodium phosphate buffer, pH 7.4, and were permeabi-
lized in PBS  3% bovine serum albumin  1% saponin  0.1%
Triton X-100 for 10 min at room temperature. The cells were
stained with antibodies against ZO-1 (ms, mc, 1:200), Alexa
Fluor 594- or 647-coupled phalloidin (Invitrogen) and anti--
catenin (ms, mc, 1:200; BD Bioscience). Secondary antibodies
(anti-mouse Alexa Fluor 546 and 647) were purchased from
Invitrogen. The samples were imaged with a confocal micro-
scope (Leica SP5), and z-stacks were projected onto three-di-
mensional reconstructions by using Volocity 4.1 software
(PerkinElmer Life Sciences). The figures were assembled with
Photoshop CS (Adobe Systems).
Membrane Pelleting Assay and Immunoblotting—MDCK II
cells stably expressing CagA mutants (1  108 cells in two
150-mm dishes) were washed three times with PBS before
transfer into detergent free homogenization buffer (20 mM
Hepes-KOH, pH 7.2, 90 mM potassium acetate, 2 mM magne-
sium acetate, 25 mM sucrose, proteinase inhibitors, and phos-
phatase inhibitor mixture 2 from Sigma-Aldrich). The cells
weremechanically broken via Branson sonifier 250 at 4 °C (duty
cycle, 50%; output control at Microtiplimit, level 1 for 15 s;
pause, 1 min; level 2 for 10 s). After centrifugation at 100,000 
g for 45 min at 4 °C in a Beckman Coulter Type 100 Ti rotor,
supernatant was removed, and pellet was resuspended in equal
volumes of homogenization buffer. Respective protein samples
were boiled in SDS sample buffer containing dithiothreitol
(final concentration, 50 mM) for 10 min and separated in SDS-
polyacrylamide gels as described previously (29). After transfer
to Immobilon-FL 0.45-m polyvinylidene fluoride membranes
(Millipore), the proteins were blocked with LI-COR blocking
buffer (Li-Cor, Germany) in PBS (1:1) for 1 h at room temper-
ature. Primary antibodies and fluorescence-labeled secondary
antibodies (1:30,000) were diluted in T-PBS (PBS  0.1%
Tween 20) and incubated for 1 h at room temperature. The
membranes were scanned with Odyssey infrared imaging sys-
tem (Li-Cor) at 680- and 800-nmwavelengths, and the amount
of protein per lane was determined with Odyssey software 1.2.
Primary antibody against CagA (rabbit, polyclonal, 1:3000) was
made against recombinant GST-CagA1–877 fusion protein
expressed in Escherichia coli (30). Anti-E-cadherin (ms, mc,
1:3000) was purchased from BD Bioscience, anti-actin (ms, mc,
1:1000) was from Sigma-Aldrich, and anti-Mek-1 (clone H-8,
ms, mc, 1:1000) was from Santa Cruz. Alexa-Fluor 680 goat
anti-mouse was purchased from Invitrogen, and anti-rabbit
IRDye 800 was from Rockland Immunochemicals.
Apical Constriction and Cell Elongation Assay—Polarized
MDCK II cells were transiently transfected with CagA and
CagA mutant plasmids. To measure apical surface area, we
stained epithelial cells with antibodies against ZO-1 and iden-
tified transfected cells via GFP fluorescence signal. Confocal
optical sections from random fields were collapsed into single
projections. Apical surface areas of individual cells were deter-
mined as the area confined byZO-1 andmeasured using ImageJ
software (National Institutes of Health). For the cell elongation
assay, CagA or CagA mutant transfected cells were evaluated
for cellular protrusion formation. Protrusions extending the
diameter of the main cell body were counted as positive for cell
elongation. CagA-expressing cells were evaluated independent
of their expression level, and the numbers of cells were counted
as indicated in the figure legends.
Hanging Drop Adhesion Assay—The assay was performed as
described before (31). In brief, MDCK II cell lines stably
expressing CagA or CagA mutants were grown at low density,
and expression was induced 24 h before the experiment. The
cells were trypsinized, centrifuged, and resuspended as single-
cell suspensions at 2.5  105 cells/ml. Twenty-microliter drops
of cell suspension were pipetted onto inside surface of six-well
cell culture dish lids, and the wells were filled with 2 ml of
medium each to prevent evaporation. At 4 h, the lid was
inverted, and the drops were spread onto a glass slide. For trit-
Intrinsic Inhibitory Domain of CagA
9000 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 • NUMBER 11 • MARCH 18, 2011
uration, the drops were first pipetted 10 times through a 20-l
pipette. At each time point, three drops were photographed,
and the numbers and sizes of clusters were determined.
TCF/-Catenin Transcriptional Activity—NCI-N87 cells
were cultured in 24-well plates and grown to 60% confluence.
The cells were co-transfectedwith 100 ng of Topflash, 100 ng of
Fopflash (kindly provided byW. J.Nelson, StanfordUniversity),
100 ng of pTeton-Advanced (Clontech), and 300 ng of CagA
WT or CagA 200–1216 cDNA, respectively. CagA expression
was activated using 3 g/ml doxycycline. After 24 h, the cells
were harvested in 100 l of reporter lysis buffer (Promega), and
luciferase activity was determined in a dual channel lumino-
meter according to manufacturer’s protocol for a dual lucifer-
ase reporter assay system (Promega). The results were normal-
ized for transfection efficiency by co-transfection of 6.25 ng of
Renilla luciferase plasmid (kindly provided by W. J. Nelson,
Stanford University).
Statistics—Themean values and S.E. were calculated from at
least three independent experiments. For statistical analysis,
one-way analysis of variance, Student’s t test, Tukey’s multiple
comparison test, Cochran-Mantel-Haenszel test, and Wilc-
oxon rank-sum test were used as indicated in figure legends (R
project for statistical computing, R version 2.8.1 for Mac OS X,
GNU Project, and GraphPad Prism, Graph Pad Software).
RESULTS
Because CagA targeting to the membrane is important for
host signaling (16, 25, 26), we re-evaluated the capacity of var-
ious truncatedCagAmutants (Fig. 1) to target the protein to the
epithelial plasma membrane. The CagA sequence was derived
from the H. pylori strain G27, and CagA mutants were
expressed in MDCK II cells as a model for polarized epithelial
cells (25, 32, 33). All of the CagA constructs were tagged with
GFP at the N terminus of CagA and transiently or stably
expressed in a doxycycline-inducible gene expression system.
By the addition of doxycycline to the growth medium, CagA
expression is turned on within hours.
CagA C Terminus Directs CagA to the Host Cell Membrane
Compartment—It has been reported that CagA derived from
the H. pylori NCTC11637 strain interacts with the plasma
membrane via the EPIYA motifs of CagA in undifferentiated
epithelial gastric cancer cells. A cagA deletion mutant lacking
the EPIYAmotifs in the C terminus did not co-localize with the
membrane compartment in AGS cells (26). Therefore, we
examined whether the EPIYAmotif containing the C terminus
is sufficient for this interaction. In our study, a CagA mutant
containing the EPIYAmotifs (CagA 800–1216) localized in the
cytoplasm when transiently transfected in polarized MDCK II
cells (Fig. 2A). This confirms the finding in a previous study
using aCagA871–1216mutant derived from the sameH. pylori
strain G27 (25). Because a cytoplasmic immunofluorescence
signal couldmask co-localizationwith themembrane compart-
ment, we analyzed the distribution of CagA 800–1216 between
membrane and cytoplasm in a biochemicalmembrane pelleting
assay using MDCK II cells stably expressing CagA and CagA
mutants under the control of a doxycycline-inducible gene
expression system.
In this assay, the cells were broken mechanically in a buffer
without detergents to preserve lipid membrane particles. This
was followed by high speed ultracentrifugation, which pellets
particles and separates them from the soluble content of the
cytoplasm. A marker for plasma membrane, E-cadherin, is
localized in the pellet fraction, whereas a marker for cytoplas-
mic proteins, Mek-1, is in the supernatant (Fig. 2B). Approxi-
mately two-thirds of the CagA 800–1216 mutant protein were
detected in themembrane fraction (Fig. 2B), indicating an indi-
rect or direct interaction of this part with the membrane com-
partment. These data suggest that the EPIYA-containing C ter-
minus interacts with membrane fractions but is not sufficient
for a complete membrane association in epithelial cells.
To determine which other parts of CagA are necessary for a
complete co-localizationwith themembrane compartment, we































































































FIGURE 1. CagA and CagA mutants. A, B, and C, maps of CagA WT and mutants. A, B, and C, immunoblots (IB) of CagA WT and mutants. *, specific bands
A. The size difference between CagA 200 – 800 and 200 – 800 is due to an additional SBP/CBP tag in CagA 200 – 800.
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CagA mutant consisting of AA 400–1216 (CagA 400–1216)
was similar to CagA 800–1216 in its subcellular localization
(Fig. 2A). In contrast, an extended CagAmutant AA 200–1216
(CagA 200–1216) localized exclusively to the membrane com-
partment as assessed by immunofluorescence with a strong
localization to the apical membrane compartment in polarized
epithelial cells (Fig. 2A). In themembrane pelleting assay, CagA
200–1216 localized completely with the membrane fraction,
confirming the immunofluorescence result (Fig. 2B).
The ability of CagA 200–1216 to localize to themembrane is
not dependent on the CagA segment 200–400 alone, because a
CagA 200–800 fragment is distributed similarly to CagA 800–
1216 throughout the cytoplasm when assessed by immunoflu-
orescence staining (Fig. 2A). The high speed centrifugation step
revealed that 46% of the mutant protein associated with the
membrane compartment (Fig. 2B).
To show that the cellular localization of theCagAC-terminal
mutant proteins is independent of cell lines, we expressed the
CagA fragments transiently in the gastric epithelial cell line
NCI-N87. Both analyzed constructs, CagA 800–1216 and
CagA 200–1216, behaved similarly in regard to their cellular
distribution in these cells as shown forMDCK II cells (Fig. 2C).
A previous report demonstrated that a N terminus fragment
of CagA (AA 1–877) interacts with the C terminus fragment
(AA 871–1216) when transiently expressed in trans in epithe-
lial cells. Thus, the C-terminal part (AA 871–1216) is directed
from the cytoplasm to the membrane compartment (25).
Therefore we asked whether the CagA fragments AA 200–800
and AA 871–1216 are able to interact with each other. The
localization of RFP-CagA 871–1216 in transiently transfected
polarized MDCK II cells is similar to GFP-CagA 800–1216
(compare Figs. 3A and 2A). When ectopically expressed in the
same cell, the mutant proteins GFP-CagA 200–800 and RFP-
CagA 871–1216 co-localized with each other primarily at the
membrane compartment (Fig. 3B). These data suggest that
CagA 200–800 and the EPIYAmotifs containing C terminus of
CagA (871–1216) interact with each other, forming a domain
that targets the CagA protein directly or indirectly to themem-
brane compartment.
CagAN Terminus Directs CagA to the Host Cell Membrane
Compartment—It has been published that the N terminus of
CagA (CagA 1–877) interacts with the plasma membrane
independent of the CagA C terminus (25). Because CagA
200–800 located only partially to the membrane compart-
ment (Fig. 2, A and B), we analyzed the first 200 AA of the N
terminus in regard to its capacity to co-localize with the
membrane compartment.
Transient expression of a CagA 1–200 fragment in polarized
MDCK II cells reveals that this fragment is sufficient to co-lo-
calize with the membrane compartment (Fig. 4A). The cellular
distributionwas again confirmed usingNCl-N87 cells (Fig. 4A).
FIGURE 2. C-terminal CagA membrane-targeting domain. A, cellular distri-
bution of CagA mutants in MDCK II cells. Shown are three-dimensional recon-
structions of confocal z-stacks (3D-View) and representative x-y or x-z planes
of corresponding confocal z-stacks. Green, GFP-CagA mutants; red, ZO-1.
B, membrane pelleting assay. The signal intensity for each protein band was
determined as integrated intensity (counts/mm2) and expressed as percent-
ages of the sum of integrated intensities in membrane (M) and cytoplasm (C).
C, cellular distribution of CagA mutants in NCI-N87 cells. Shown are represen-
tative x-y planes of confocal z-stacks. Green, GFP-CagA mutants; red, actin; bar,
10 m.
FIGURE 3. CagA 200 – 800 and 871–1216 interact in trans. Shown are MDCK
II cells transiently expressing mRFP-CagA 871–1216 (red) alone (A) or together
with GFP-CagA 200 – 800 (green) (B). Shown are representative x-y and x-z
planes of confocal z-stacks, E-cadherin (white). Bar, 10 m.
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The ability of the N terminus of CagA to co-localize with the
plasma membrane in epithelial cells is confined to the first 200
AA. CagA mutants shorter than 200 AA (CagA 1–150) or a
mutant lacking the first 26 AA (CagA 27–225) were distributed
throughout the cytoplasm (Fig. 4B).
When expressed in nonpolarized subconfluent MDCK II
cells, CagA 1–200 was enriched at sites of cell-cell contacts
co-localizing with -catenin, a protein important for the for-
mation of cell-cell adhesion (Fig. 5A). CagA 1–200 was
excluded from membrane sites not engaged in cell-cell con-
tacts (see arrowhead in Fig. 5B). Interestingly, in nonpolar-
ized subconfluent cells, the C terminus fragment CagA 200–
1216 distributes along the entire membrane compartment
including membrane sites not engaged in cell-cell contacts
(see arrowhead in Fig. 5C). This diverse distribution pattern
of the N-terminal and C-terminal domain at the membrane
suggests that they may interact with different membrane
substructures.
Impact of Membrane-targeting Domains on CagA-induced
Cell Elongation—After identifying two distinct membrane-tar-
geting domains, we asked whether they would interfere with
each other’s role in host cell responses. Once CagA is intracel-
lular in host cells, it causes cell elongation (14, 15, 18). Bagnoli et
al. (25) showed that in polarized epithelial cells CagA-express-
ing host cells exhibit an elongated morphology with a constric-
tion of the apical surface area.
To analyze the effects of both membrane-targeting
domains on cell elongation, we counted the number of CagA
expressing cells with cellular protrusions extending the
diameter of the cell body in transiently transfected polarized
MDCK II cells (Fig. 6A). Host cells expressing CagA WT
(1–1216) developed cellular protrusions in 24.7  4% of
transfected cells (Fig. 6B). However, the formation of cellular
protrusions was significantly increased to 48.2  1.3% in
CagA 200–1216 expressing cells. The number of CagA 800–
1216-induced cellular protrusions was similar to CagA 200–
1216 (46  3.3%). CagA 1–200 had no effect on cell elonga-
tion (Fig. 6B). The decrease of cell elongation in CagA WT
compared with CagA 200–1216 expressing cells suggests
that CagA 1–200 exerts an inhibitory effect on cell signaling
mediated by the C terminus of CagA.
CagA 1–200 does not exert its inhibitory effect by acting
directly on CagA 200–1216. When co-expressed as two sep-
arate mutants in the same cell, CagA 1–200 does not inhibit
FIGURE 4. N terminus CagA membrane-targeting domain. A, confocal
microscopy images (representative x-y or x-z planes) of transient expression
of GFP-CagA 1–200 (green) in polarized MDCK II and NCI-N87 cells, actin (red).
Bar, 10 m. B, GFP-CagA 1–150 and 27–225 (green) in polarized epithelial cells
(MDCK II). Shown are three-dimensional reconstructions of confocal z-stacks
(3D-View) and representative x-y planes, ZO-1 (red). Bar, 10 m.
FIGURE 5. CagA membrane-targeting domains in nonpolarized cells.
A, CagA 1–200 (green) in nonpolarized MDCK II cells; co-localization with
-catenin (red) at lateral membrane. White arrow indicates plan of z-section of
corresponding x-y plane. B, *, enriched at cell-cell contacts; arrowhead,
excluded from free edge; red, actin. C, green, CagA 200 –1216 in nonpolarized
MDCK II cells; *, surface area free of cells; arrowhead, CagA 200 –1216 enriched
at free edge of cell; red, actin; white arrow, z-section of corresponding x-y
plane; bar, 10 m.
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CagA 200–1216-induced cell elongation (45.3  2.3%) (Fig.
6B). However, covalent binding to the signaling motifs in the
C terminus is required for the inhibitory effect. CagA 1–200,
when fused to CagA 800–1216 (CagA 200–800), tethers
the CagA C terminus to the cell membrane (compare
supplemental Fig. S2A and Fig. 2A). Epithelial cells express-
ing CagA 200–800 elongated significantly less compared
with CagA 800–1216 but similar to CagA WT (24.4  5.8%)
FIGURE 6. CagA 1–200 membrane-targeting domain inhibits cell elongation and apical surface constriction. A, CagA WT (green) induces cell elongation
(white arrow) and constriction of apical surface area (*) in polarized MDCK II cells. Shown are three-dimensional reconstruction of confocal z-stacks (3D-View)
and representative x-z plane, ZO-1 (red). Bar, 10 m. B, percentage of elongated cells transiently transfected with CagA WT or CagA mutants in polarized
epithelia; the data are presented as the means  S.E. *, p  0.05, (Student’s t test). n indicates number of cells counted in three to six independent experiments.
C, apical constriction of CagA mutants. Three-dimensional reconstruction of confocal z-stacks is shown. *, apical surface area of CagA expressing cells; green,
GFP-CagA WT, GFP-CagA mutants; red, ZO-1; bar, 10 m. D, box plot graph of apical surface area: control n 	 138, WT n 	 65, 1–200 n 	 61, 200 –1216 n 	 87,
400 –1216 n 	 100, EPISA C n 	 92, 1–200  200 –1216 n 	 85, 27–1216 n 	 89 cells. *, p  0.0001; **, p  0.05 (Wilcoxon rank-sum test).
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(Fig. 6B). These data suggest that the inhibitory effect of
CagA 1–200 is due to membrane targeting of the C-terminal
signaling motifs to an alternative membrane substructure.
Because the deletion of larger parts of a protein could cause
conformational changes, we analyzed the much shorter dele-
tionmutants of CagA (CagA 27–1216). The deletion of the first
26 AA of the CagA 1–200 fragment led to a loss of the mem-
brane-targeting domain at the N terminus as shown in Fig. 4B.
The mutant still localized to the host cell membrane, not
because of the N-terminal but likely because of the C-terminal
membrane-targeting domain (supplemental Fig. S2B). CagA
27–1216 induced cellular protrusions in 43.5  2.5% of
expressing host cells similar to CagA 200–1216 (Fig. 6B). This
further supports our hypothesis that CagA 1–200 exerts its
inhibitory effect because of targeting of C terminus signaling
motifs to an alternative membrane substructure.
CagA expression in polarized epithelial cells causes a con-
striction of the apical surface area (Fig. 6C) (25). We analyzed
the surface area ofCagAandCagAmutant expressing polarized
cells. Expression of CagA 200–1216 showed a strong constric-
tion of the apical surface area compared with nonexpressing
control cells (median surface area, 40 versus 199 relative units),
whereas CagA 1–200 had no effect on apical constriction
(median surface area, 206 relative units; Fig. 6D). However, api-
cal constriction exerted by CagAWTwas significantly reduced
compared with CagA 200–1216 (median surface area, 102 ver-
sus 40 relative units), which suggests that CagA 1–200 inter-
fered with CagA 200–1216-mediated constriction of the apical
surface area in polarized epithelia. The subcellular localization
of CagA 200–1216 to the apical membrane and phosphoryla-
tion at the EPIYA C motifs are important for apical constric-
tion. The CagA 400–1216 mutant, which localizes less to the
membrane compartment (Fig. 2A), and CagA EPISA C, a
mutant that cannot be phosphorylated at the EPIYA C motif,
did not constrict the apical surface area, respectively (median
surface area, 165 and 176 relative units, respectively; Fig. 6D).
Again, covalent binding of CagA 1–200 to signalingmotifs in
the C terminus was required for the inhibitory effect. Co-ex-
pression of CagA 1–200 and CagA 200–1216 as two separate
mutants in the same cell did not inhibit the phenotype of CagA
200–1216-induced constriction of the apical surface area
(median surface area, 63 versus 40 relative units).
The CagA mutant 27–1216, a shorter deletion mutant to
minimize the impact of conformational changes, also did not
reduce CagA 200–1216-induced apical surface constriction
(median surface area, 80 relative units). Our data suggest
that the inhibitory effect of the N-terminal domain CagA
1–200 is due to its tethering ability to a different membrane
compartment.
Impact of Membrane-targeting Domains on Cell-Cell
Adhesion—CagA-induced loss of cell-cell adhesion is a distinct
host cell response (15, 18, 25, 34, 35). Therefore, we analyzed
whether the membrane-targeting domain CagA 1–200 affects
cell-cell adhesion using a hanging drop adhesion assay, which
determines the size of cell clusters formed over time from single
cells in suspension. The application of shearing forces through
trituration reveals the strength of newly formed adhesion com-
plexes (31).
For this cell-cell adhesion assay, we used MDCK II cells sta-
bly expressing CagA and CagA mutants under the control of a
doxycycline-inducible gene expression system. These mutants
were expressed at comparable levels in 80% of cells (supple-
mental Fig. S3). The experiments were performed in triplicate
with 200–400 cells examined 4 h after forming a single cell
suspension using noninduced cells as control. In control cells,
62% of clusters consisted of more than 10 cells/cluster (sum of
gray and black areas in Fig. 7A). Interestingly, cluster formation
with more than 10 cells/cluster in CagA WT-expressing cells
FIGURE 7. Opposite effects of CagA membrane-targeting domains on cell-cell adhesion. Quantitative, functional adhesion assay of MDCK II cells stably
expressing CagA WT, 200 –1216 and 1–200 mutants. Control represents pooled data from noninduced MDCK II cells of all three clones. Graphs show percent-
ages of cells in clusters of 0 –10 cells (white), 11–50 cells (gray), and 
50 cells (black) after 4 h before (A) and after (B) trituration. The data are presented as the
averages of three independent experiments; …, not significant; *, p  0.0001; #, p  0.05 (Cochran-Mantel-Haenszel test). The photographs are representative
fields.
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was not significantly different from control cells (57%) but sig-
nificantly decreased to 39% in CagA 200–1216 mutant cells.
However, expression of the CagA 1–200 membrane-binding
domain increased the rate of cell cluster formation to 100% of
clusters with 10 or more cells (Fig. 7A).
Applying shearing forces to the clusters revealed that the
CagA 1–200 domain also increased the strength of cell-cell
adhesion in formed cell clusters (Fig. 7B). After trituration of
cell clusters formed after 4 h, the number of large cell clusters
(10–50 and
50 cells/cluster group) was similar betweenCagA
WTand control cells and significantly increased inCagA1–200
expressing cells (52% versus 54% versus 70%, respectively). Epi-
thelial cells expressing theCagA200–1216mutant formed dra-
matically weaker cell-cell adhesions (9%). These data show that
the CagA C terminus membrane-targeting domain 200–1216
mediates the loss of cell-cell adhesion and that CagA 1–200
counteracts this effect by increasing the formation and strength
of newly formed cell-cell contacts.
Impact of Membrane-targeting Domains on Transcriptional
Activity of -Catenin—Loss of cell-cell adhesion has been
linked to the ability of CagA to increase transcriptional activity
of -catenin (17, 34, 36). Cell-cell adhesion is mediated by
adherens junctions, which consist of the transmembrane pro-
tein E-cadherin binding directly to -catenin. This interaction
is stabilized when cell-cell contacts are established (37). A dif-
ferent role of -catenin is its function as a transcriptional reg-
ulator of gene expression in the nucleus by binding to TCF/
lymphoid enhancer factor transcription factors (38). CagA has
been described to disrupt the E-cadherin/-catenin complex
leading to a weakening of cell-cell adhesion and to an increase
of transcriptional activity of -catenin (17, 34, 36). CagA
induced an increase in TCF/-catenin transcriptional activity,
which ismediated by theCM/CRPIAmotif in theC terminus of
CagA (23), has been shown in cell lines with a constitutive TCF/
-catenin transcriptional activity (34, 36). In our model for
polarized epithelial cells, TCF/-catenin-mediated transcrip-
tion is not constitutively activated (39), and CagA WT did not
alter TCF/-catenin transcriptional activity (TOP) compared
with the control with a mutated TCF-binding site (FOP) (sup-
plemental Fig. S4). Therefore, we tested the impact of CagA
WT and the CagA 200–1216 membrane-targeting domain on
-catenin transcriptional activity in the gastric epithelial cell
line NCI-N87, which forms adherens junctions and has consti-
tutive TCF/-catenin transcriptional activity (40). The CagA
1–200 and CagA 200–1216 mutants behaved similarly in
regard to membrane targeting in these cells as shown for
MDCK II cells (Figs. 2 and 4). The baseline transcriptional
activity of -catenin is increased in NCI-N87 cells (Fig. 8). The
CM/CRPIA motif containing CagA mutant 200–1216
increased TOP luciferase activity as a read-out for -catenin
transcriptional activity by 2.65-fold to control cells (p 
0.0001). Consistent with its stimulating effect on cell-cell adhe-
sion, the CagA 1–200 membrane-binding domain bound to
CagA 200–1216 attenuated CagA 200–1216-induced
-catenin transcriptional activity by 27% because CagA WT-
induced TOP luciferase activity was only 1.93-fold compared
with control (p  0.0001).
DISCUSSION
It has been demonstrated before that targeting ofCagA to the
membrane is an essential prerequisite for the effects of CagAon
host cells. CagA specifically binds to and activates Src homol-
ogy 2-containing protein-tyrosine phosphatase-2 at the mem-
brane via EPIYA motifs in the C terminus of CagA, thereby
inducing cell elongation in host epithelial cells. Membrane tar-
geting of activated Src homology 2-containing protein-tyrosine
phosphatase-2 is necessary and sufficient for the induction of
this phenotype (16, 26). In a second study in polarized epithelial
cells, membrane targeting of CagA was important for detach-
ment of host cells from neighboring cells during cell migration
(25).
Despite the significance of CagA membrane targeting for its
effect on host cell signaling, until now only two studies have
addressed the question ofwhich domains ofCagAare necessary
for its tethering to the membrane compartment. The results
appeared to be inconsistent at first glance (25, 26): a CagA
mutant lacking EPIYAmotifs in the C terminus of CagA (CagA
868–1087) no longer co-localized with the membrane com-
partment. These data showed that EPIYA motifs are required
for CagA membrane targeting (26). In contrast, Bagnoli et al.
(25) showed that a CagA mutant lacking the entire C terminus
including EPIYA motifs (CagA 878–1216) co-localized
entirely with the plasmamembrane, suggesting thatmembrane
targeting of CagA is independent of EPIYAmotifs. In addition,
the EPIYAmotif containing C terminus of CagA (CagA 871–
1216) alone is not sufficient to co-localize with the mem-
brane (25). The difference could be due to sequence diver-
gence in CagA (H. pylori strain NCTC11637 versus G27),
host cell variations of used cell lines (AGS versus MDCK II
cells), or the experimental set-up evaluating membrane tar-
geting by immunofluorescence microscopy. Data from our
study give further insight into the mechanism of membrane
targeting.
Using immunofluorescence analysis, we confirmed the find-
ing by Bagnoli et al. (25) that CagA 800–1216 alone localizes to
FIGURE 8. CagA 1–200 bound to CagA 200 –1216 decreases TCF/-catenin
transcriptional activity of the C terminus. Shown is the TCF/-catenin tran-
scriptional activity of NCI-N87 cells transiently transfected with CagA WT,
CagA 200 –1216, or empty vector. The data represent the means  S.E. calcu-
lated from three independent experiments as x-fold induction compared
with activity of reporter vector in the absence of CagA. *, p  0.0001 (one-way
analysis of variance; Tukey’s multiple comparison test); black, TOPflash; white,
FOPflash.
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the cytoplasm.However, using a biochemicalmembrane pellet-
ing assay, we could show that approximately two-thirds of the
protein can still be detected in themembrane fraction, suggest-
ing that CagA 800–1216 interacts to some degree with mem-
branes and the immunofluorescence signal in the cytoplasm
masked co-localization with the membrane compartment. For
a completemembrane targeting of the C terminus, amino acids
200–1216 are required. Segments 200–800 and 800–1216
interact with each other and seem to form a domain that is
responsible for co-localization with the membrane compart-
ment. Neither of them alone has this capacity for complete
membrane targeting.
In addition, we were able to show in this study that CagA
exhibits a second membrane-targeting domain. Previously
published data showed that a CagA mutant consisting of the
first 600 AA localizes to the plasma membrane of epithelial
cells (25). We were able to narrow down this second mem-
brane-targeting domain to the first 200 AA of the N termi-
nus. Because CagA 27–225 and CagA 1–150 are no longer
able to localize to the membrane, CagA 1–200 is required for
its targeting ability.
Membrane targeting has an important impact on host cell
responses, hence interaction with host cell proteins. Twenty
different host cell proteins have been identified so far to interact
directly or indirectly with CagA (24). Most of these proteins
interact with signaling motifs in the C terminus of CagA like
EPIYAandCM/CRPIAmotifs (23, 41, 42). Early in the course of
infection, CagA is interacting with the host membrane compo-
nent phosphatidylserine close to the injection site at the mem-
brane likely at the apical membrane of polarized epithelia (33,
35, 43). However,many of the host signaling proteins like Par-1,
focal adhesion kinase, E-cadherin, ZO-1, and JAM-1, with
which CagA interacts, are confined to basal-lateral membranes
in polarized epithelia (32, 44–46). Different hypotheses have
been proposed regarding how CagA could interact with pro-
teins of the basal-lateral membrane compartment. H. pylori
infectionmay cause localization of basal-lateralmembrane pro-
teins to the apical membrane prior to CagA injection (47), or
CagA-induced loss of cell polarity causes mislocalization of
proteins to the apical compartment, which would otherwise be
confined to basal-lateral membranes (33, 41). Our data lead to
the suggestion that the second membrane-targeting domain
would give a bacterial effector protein the ability to localize to a
membrane compartment away from the injection site so that it
can recruit and interfere with other host-signaling proteins. In
subconfluent cells, the N terminus membrane-targeting
domain CagA 1–200 co-localizes mainly with membranes
engaged in cell-cell contacts, whereas CagA 200–1216 also co-
localizes with membranes that are not engaged. This suggests
that the CagA membrane-targeting domains interact with dif-
ferent membrane substructures.
The CagA 1–200 domain had an inhibitory effect on host
cell responses mediated by signaling motifs of the C termi-
nus. CagA 200–1216 displayed a significantly greater effect
on host cell elongation and constriction of the apical surface
area compared with wild type CagA. The concept that CagA
function is regulated by the interplay of two membrane-tar-
geting domains is emphasized by the observation made with
a CagA 200–800 mutant, where CagA 1–200 tethers CagA
800–1216 to the membrane compartment. The effect of
CagA 800–1216 on cell elongation is significantly reduced in
CagA 200–800. Disruption of the N-terminal membrane-
targeting domain (CagA 1–200) through the deletion of the
first 26 AA abolishes its inhibitory effects on C terminus-
mediated changes in host cell morphology. The covalent
bond between CagA 1–200 and the C terminus is essential
for its inhibitory effect, because when expressed in trans,
CagA 1–200 loses its inhibitory function on CagA 200–1216.
Together these data suggest that tethering of signaling
motifs in the C terminus of CagA via the N terminus domain
1–200 to a different membrane substructure influences host
cell responses.
Whereas CagA 1–200 does not have an effect on cell elonga-
tion or apical surface constriction on its own, we could show
that it increases the formation of cell-cell adhesion. This obser-
vation is contrary to the well established fact that CagA induces
cell scattering in subconfluent cells (14, 15, 23, 48). Using a
cell-cell adhesion assay, we eliminated the influence of cell-
extracellular matrix interaction, because cell-cell and cell-ex-
tracellular matrix adhesion are interdependent processes (49,
50). In this setting, CagAWT-expressing cells are not different
in rate of cell-cell contact formation or in strength of formed
contacts compared with control cells. The C terminus mem-
brane-targeting domain CagA 200–1216 causes the loss of cell-
cell adhesion as it decreases the rate of formation and the
strength of newly formed cell-cell contacts significantly. This is
counteracted by a considerable increase of cell-cell adhesion
through the CagA N terminus membrane-targeting domain
1–200. The observed difference to subconfluent cells attaching
to a surface area, where CagAWT induces cell scattering, could
be due to increased cell motility, hence changes in cell-extra-
cellular matrix interaction exerting additional effects on cell-
cell adhesion (47, 50). However, in a complex network of epi-
thelial cells in gastric tissue in vivo, where CagA-induced cell
scattering has not been observed, the direct effect of CagA on
cell-cell adhesion may play a bigger role than in subconfluent
cells in vitro.
The impact of CagA on cell-cell adhesion has been linked to
its ability to stimulate TCF/-catenin transcriptional activity.
Increased TCF/-catenin transcriptional activity is associated
with cancer formation, and it has been suggested that CagA
may exert its carcinogenic effects through this pathway (51).
The current understanding is that CagA destabilizes the E-cad-
herin/-catenin complex at cell-cell junctions, which causes
loss of cell-cell adhesion and increase of cytoplasmic -catenin
(17, 34, 36). The CagA membrane-targeting domain 1–200 co-
localizes with -catenin by immunofluorescence at the lateral
membrane of newly formed cell-cell contact sites in subconflu-
ent epithelial cells, and it increases the formation of cell-cell
adhesion. These functional data suggest that CagA 1–200 sta-
bilizes the cadherin/catenin protein complex. Consistent with
this finding is that CagA 1–200 covalently bound toCagA 200–
1216 decreasesTCF/-catenin transcriptional activity, which is
induced by the C-terminal CagA membrane-targeting domain
alone.
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Although this study did not test the role of the bacterial effec-
tor protein CagA for carcinogenesis, our data imply that the
CagAmembrane-targeting domain 1–200 could be an intrinsic
inhibitor of the carcinogenic potential of CagA. Therefore, bac-
terial or host factors that would alter the inhibitory effect of the
N-terminal membrane-targeting domain of CagA could have
an impact on gastric carcinogenesis.
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